lessthanhalf said:
Jfrick11 said:
lessthanhalf said:
Beardboost said:
I doubt it will make it anywhere near trial approval — the danger profile is just too large. Amylin slows digestion down even further, wipes out cravings (that part is good) and leaves you feeling stuffed for hours on end, which raises the odds of heart burn, plus you end up eating far below what your body actually needs to stay healthy. Then Calcitonin enters the picture and cuts the brain off entirely from hunger signals. When GLP-1's help with weight loss and mental health, I'm all for them, but I strongly believe in pairing any GLP with real lifestyle changes — planning meals, eating on a steady schedule, building habits you can actually sustain so the weight stays off. Shutting hunger out of the mind completely while cutting food intake is a wrecking ball waiting to happen.
A number of members here are already, in practice, using a very close combination: reta along with cagrilintide, and for them it has been working rather effectively.
One clear situation in which GLP drugs deliver weaker weight loss results is among diabetics. Even when blood sugar control is excellent, the pounds shed tend to be noticeably lower than what non diabetics experience, which is why weight loss trials are run separately for those two populations. That makes diabetics another group who might gain from improved GLP options.
I would like to hear how severe the obesity is that Beardboost is addressing through GLP's alongside lifestyle, diet and exercise. The view that GLP's play only a modest role in the overall solution tends to come from individuals who are not dealing with severe obesity. If my guess about where this poster is coming from is mistaken, please set me straight.
Among people whose obesity is more severe, many have devoted decades to losing and keeping off weight through diet, exercise and lifestyle changes, only for those efforts to work at best temporarily. For them, GLP medications are the answer. They also make subsequent adjustments to lifestyle, diet and exercise simpler and easier to sustain. Those things are not meaningless, but decades of personal experience and a large body of scientific research indicate they mostly fail to produce or hold onto substantial weight loss, apart from a fortunate or unusually determined minority. GLP medications, by contrast, show strong success rates, though not universally, and keep that weight off over the long term as long as the medication is continued.
There’s a chunk of your argument I’m on board with, particularly when it comes to severe obesity. For many individuals, medication ends up being the first intervention that delivers lasting results after years of cycling through every other option.
And the distinction between diabetic and non diabetic outcomes is real, that part isn’t up for debate.
Where I’d push back is the idea that meds are the answer and that for this group, everything else barely moves the needle.
Take something like Retaor stacked with Cagri. What the drug is doing is altering appetite, satiety, and how glucose is processed. The fundamental physiology underneath isn’t being swapped out.
When someone has severe obesity, those deeper drivers tend to be louder, not quieter. Insulin runs higher, metabolic adaptation is greater, and the body fights weight loss harder. A more potent medication doesn’t erase any of that.
On top of that, plenty of people have tried diet and exercise, but not in a form that protects muscle, keeps metabolism supported, or can be maintained over time. Years of undereating plus cardio is a totally different animal from eating enough, making protein a priority, and lifting weights consistently.
Do the meds make all of that more manageable? 100%. But those behaviors still shape how far a person gets and whether progress grinds to a halt.
So framing it as meds against lifestyle doesn’t fit for me.
What’s really happening is that the meds finally let lifestyle changes do what they were always meant to do.
GLP medications genuinely address many of the metabolic issues underneath: they lower blood sugar, blood pressure, lipids and insulin resistance, partly through direct drug action and partly because of the weight that gets lost.
When diet and exercise are used as the answer to obesity, even in a highly optimized form, the difficulty lies in the long run. Sustaining that requires deliberate mental effort or restraint, or at least almost always does; turning improved health behaviors into automatic habits is not impossible, but it is hard and most people fail to do it. And the trouble with relying on cognitive effort to solve a long-term problem is that people simply have finite reserves of it, and those reserves eventually run dry. Keeping up that effort is draining both mentally and physically, so eventually old behavior patterns return. To be fair, people with particularly severe obesity are on average probably worse than average at sticking with healthy eating and exercise, which is undoubtedly part of why they became obese. That is not a moral failure; it is just normal human variation, combined with an obesogenic environment, and once obesity develops, exercising becomes harder, and the appetite regulation system begins to progressively malfunction as hormonal and neurotransmitter regulatory systems stop working correctly under the metabolic stress of obesity.
Before GLP drugs existed, long-term weight loss of 5% or more, and rarely 10%, was regarded as a major success in diet-and-exercise treatment for obesity, since even this modest loss substantially lowers long-term health consequences. Everything I have ever seen indicates that any weight-loss intervention short of surgery fails over the long term, with nearly everyone regaining the weight eventually after the intervention stops, and sustaining any intervention long term runs straight into the cognitive effort or cognitive restraint problem.
GLP drugs sidestep the cognitive effort problem entirely, because 1 injection per week is not exactly difficult compared with adhering to a 1600 or 1800 calorie diet long term, and over time they simply keep working as long as you keep taking them. In my view, the evidence from the studies and on this forum demonstrates their effectiveness well, and shows that it is maintained long term. Better diet and exercise matter, but people who take GLP drugs for obesity without making any special lifestyle effort still lose weight. There is also evidence that GLP drugs improve people's food choices, and from personal experience it is far easier to exercise at normal or near-normal weights than when severely obese.
My position is that diet and exercise are a largely ineffective therapy for obesity, judging by long-term results from thousands of studies across decades: not completely useless or pointless, but with very poor long-term success rates. GLP drugs simply work, aside from a few people who get bad side effects or respond poorly to them. For the large majority, though, they enable significant long-term weight loss of 10-30%, with extra health benefits as a bonus.
